Siga Technologies (SIGA) EBT Margin (2010 - 2025)
Siga Technologies' (SIGA) quarterly EBT Margin came in at 318.93% in Q3 2025, down 33763.0% on a YoY basis from N/an in Q3 2024, and down 647.29% quarter-over-quarter from 58.27% in Q2 2025.
Powered by 
Analysis
Siga Technologies (SIGA) EBT Margin (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported EBT Margin for 16 consecutive years, with 318.93% the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, EBT Margin fell 33763.0% year-over-year to 318.93%; the trailing twelve-month figure through Sep 2025 stood at 56.27% (down 725.0% YoY), and the FY2024 full-year result was 54.84%, down 790.0% from the prior year.
- EBT Margin declined to 318.93% in Q3 2025 per SIGA's latest filing, from 58.27% in the prior quarter.
- Across five years, EBT Margin topped out at 81.38% in Q4 2021 and bottomed at 318.93% in Q3 2025.
- Historically, EBT Margin has averaged 3.77% across 5 years, with a median of 5.4% in 2021.
- The sharpest annual moves came in 2021 and 2025: EBT Margin soared 42108 bps in 2021, then plunged 33763 bps in 2025.
- Over 5 years, EBT Margin stood at 81.38% in 2021, then plunged by 112 bps to 9.93% in 2022, then soared by 903 bps to 79.73% in 2023, then declined by 10 bps to 71.91% in 2024, then sank by 544 bps to 318.93% in 2025.
- According to Business Quant data, EBT Margin over the past three periods registered 318.93%, 58.27%, and 8.1% for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 29.63% |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -4.34% |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 12.17% |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 44.89% |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 47.58% |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -318.93% |
| Jun 30, 2025 | 58.27% |
| Mar 31, 2025 | -8.10% |
| Dec 31, 2024 | 71.91% |
| Sep 30, 2024 | 18.71% |
| Jun 30, 2024 | 10.99% |
| Mar 31, 2024 | 51.98% |
| Dec 31, 2023 | 79.73% |
| Sep 30, 2023 | -4.61% |
| Jun 30, 2023 | -58.65% |
| Mar 31, 2023 | -14.63% |
| Dec 31, 2022 | -9.93% |
| Sep 30, 2022 | 59.73% |
| Jun 30, 2022 | 19.16% |
| Mar 31, 2022 | -10.10% |
| Dec 31, 2021 | 81.38% |
| Sep 30, 2021 | -82.21% |
| Jun 30, 2021 | 5.40% |
| Mar 31, 2021 | -21.71% |
| Dec 31, 2020 | 69.57% |